Insiders Collegium Pharmaceutical, Inc.

Equities

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-10 EDT			5-day change	1st Jan Change
31.5 ^USD	-16.80%		-16.02%	+2.34%

05-10	Needham Downgrades Collegium Pharmaceutical to Hold From Buy	MT
05-10	Piper Downgrades Collegium Pharmaceutical to Neutral From Overweight, Price Target at $39	MT

Collegium Announces CEO Transition	05-09	CI
Collegium Announces President and Board Changes	05-09	CI
Collegium Pharmaceutical Insider Sold Shares Worth $2,075,086, According to a Recent SEC Filing	12-21	MT
Insider Sell: Collegium Pharmaceutical	23-06-28	MT
Insider Sell: Collegium Pharmaceutical	23-06-05	MT
Insider Sell: Collegium Pharmaceutical	23-03-17	MT
Insider Sell: Collegium Pharmaceutical	23-03-03	MT
Insider Sell: Collegium Pharmaceutical	23-02-14	MT
Insider Sell: Collegium Pharmaceutical	23-02-14	MT
Insider Sell: Collegium Pharmaceutical	23-01-11	MT
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors	23-01-04	AQ
Insider Sell: Collegium Pharmaceutical	22-12-28	MT
Insider Sell: Collegium Pharmaceutical	22-12-22	MT
Insider Sell: Collegium Pharmaceutical	22-12-15	MT
Insider Sell: Collegium Pharmaceutical	22-12-06	MT
Insider Sell: Collegium Pharmaceutical	22-09-16	MT
Collegium Pharmaceutical, Inc. Appoints Neil McFarlane to its Board of Directors	22-04-06	CI
Collegium Pharmaceutical, Inc. Announces Executive Changes	21-09-30	CI
Insider Trends: Collegium Pharmaceutical Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected	21-06-03	MT
Insider Trends: Collegium Pharmaceutical Insider Continues 90-Day Selling Trend	21-05-12	MT

No results for this search